10-Q: USANA Health Sciences Reports First Quarter 2024 Results with Sales Decline

USANA Health Sciences reported a decrease in net sales and earnings for the first quarter of 2024, primarily due to lower customer spending and unfavorable currency exchange rates.

Summary

• USANA Health Sciences reported a net sales decrease of 8.3% to $227.8 million for the first quarter of 2024, compared to $248.36 million in the same period last year.
• The decline in sales was mainly due to a decrease in average customer spending, partially offset by a slight increase in active customers and modest price increases.
• Unfavorable currency exchange rates negatively impacted net sales by an estimated $7.2 million.
• Net earnings for the quarter decreased by 10.0% to $16.5 million, compared to $18.4 million in the prior-year quarter.
• The decrease in net earnings was primarily due to decreased sales and higher relative income taxes.
• The company had approximately 494,000 active customers worldwide as of March 30, 2024.
• Gross profit increased to 81.1% of net sales, up from 80.5% in the prior-year quarter, due to favorable changes in market and product sales mix, a decrease in inventory scrap charges, and modest price increases.
• Associate incentives decreased to 42.0% of net sales, down from 42.7% in the prior-year quarter, due to modest price increases and decreased spend on promotional incentives.
• Selling, general, and administrative expenses increased relative to net sales due to a loss of leverage on lower year-over-year net sales.

Sentiment

Score: 4

Explanation: The document presents a mixed picture with a decline in sales and earnings, but some positive aspects like increased gross profit margin. The overall sentiment is negative due to the worse than expected results.

Positives

• Gross profit margin increased to 81.1% of net sales due to favorable changes in market and product sales mix, a decrease in inventory scrap charges, and modest price increases.
• Associate incentives decreased to 42.0% of net sales due to modest price increases and decreased spend on promotional incentives.
• The company saw a slight increase in active customers.

Negatives

• Net sales decreased by 8.3% to $227.8 million.
• Net earnings decreased by 10.0% to $16.5 million.
• Unfavorable currency exchange rates negatively impacted net sales by an estimated $7.2 million.
• Selling, general, and administrative expenses increased relative to net sales.
• Diluted earnings per share decreased by 9.5% to $0.86.
• There was a decrease in average spend per customer.

Risks

• The company's business is subject to fluctuations in currency exchange rates, which can significantly affect reported U.S. dollar sales and earnings.
• The company is dependent on the direct selling business model and the activities of its independent associates.
• The company faces extensive regulation of its business model, particularly in the United States and China.
• The company's operations in China are subject to risks related to operating in China, direct selling regulations, data privacy laws, and changes in the Chinese economy.
• Macroeconomic conditions, including inflationary pressures and slower economic growth, can affect consumer spending and the company's supply chain.
• The company is exposed to risks related to political events, natural disasters, pandemics, and geopolitical tensions.
• The company faces risks related to data privacy and security laws, as well as potential security breaches.
• The company is subject to risks related to shortages of raw materials, disruptions in contract manufacturing, and price increases of key raw materials.
• The company must comply with debt covenants in its credit facility.
• The company faces litigation, tax, and legal compliance risks and costs.
• The company is exposed to risks related to information technology system failures, data security breaches, and cybersecurity attacks.
• The company faces risks related to acquisitions, divestitures, and investments.

Future Outlook

The company believes its current cash balances, future cash provided by operations, and amounts available under its line of credit will be sufficient to cover its operating and capital needs in the ordinary course of business for the foreseeable future. The company is actively assessing potential acquisition opportunities and investments in complementary ventures.

Management Comments

• Management believes that presentation of certain non-GAAP financial information is meaningful and useful in understanding the activities and business metrics of our operations.
• Management believes that the company's focus on increasing the number of active customers is consistent with its vision of improving the overall health and nutrition of individuals and families around the world.

Industry Context

The direct selling industry is facing challenges due to changing consumer preferences and increased competition. USANA's results reflect these broader industry trends, with a focus on customer acquisition and retention being critical for future growth. The company's performance in different geographic regions highlights the varying market dynamics and the need for tailored strategies.

Comparison to Industry Standards

• USANA's gross profit margin of 81.1% is relatively high compared to some direct selling companies, indicating strong pricing power or efficient cost management.
• However, the decrease in net sales and earnings is a concern, as many direct selling companies are experiencing similar challenges in customer acquisition and retention.
• Companies like Herbalife and Nu Skin, which also operate in the nutritional and personal care space, have reported mixed results recently, reflecting the competitive landscape.
• USANA's performance in China, with a 10.0% increase in local currency net sales, contrasts with some other companies that have faced regulatory and market challenges in the region.
• The company's reliance on the direct selling model is a common factor with other companies in the industry, but the success of this model is increasingly dependent on digital marketing and customer engagement strategies.

Stakeholder Impact

• Shareholders may be concerned about the decrease in sales and earnings, which could negatively impact the stock price.
• Employees may be affected by potential cost-cutting measures or changes in the company's strategy.
• Associates may experience changes in their earnings due to fluctuations in sales and incentives.
• Customers may be impacted by changes in product availability or pricing.

Next Steps

• The company will continue its efforts to ensure that the control deficiencies contributing to the material weaknesses are remediated.
• The company will review and update IT policies, analyze current processes and control documentation, and establish the appropriate level of responsibility and ownership of ITGCs.
• The company expects that the remediation of these material weaknesses will be completed prior to the end of fiscal year 2024.

Key Dates

Keywords

direct selling, nutritional products, personal care, skincare, USANA, financial results, sales, earnings, currency exchange, active customers, China, Asia Pacific, Americas and Europe